We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$2.06B
AUM Growth
+$107M
Cap. Flow
-$28.6M
Cap. Flow %
-1.39%
Top 10 Hldgs %
29.47%
Holding
2,720
New
413
Increased
568
Reduced
616
Closed
259

Sector Composition

Rank Sector Weight
1 Technology 24.3%
2 Healthcare 11.82%
3 Financials 10.45%
4 Consumer Discretionary 9.39%
5 Industrials 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNK icon
1676
Genco Shipping & Trading
GNK
$1.1B
$32.3K ﹤0.01%
+2,304
New +$33.1K
PRME icon
1677
Prime Medicine
PRME
$580M
$32.3K ﹤0.01%
2,203
+1,485
+207% +$20.7K
EHAB
1678
DELISTED
Enhabit
EHAB
$32.2K ﹤0.01%
+2,804
New +$35K
TWI icon
1679
Titan International
TWI
$450M
$32.2K ﹤0.01%
2,805
+549
+24% +$5.82K
CEVA icon
1680
CEVA Inc
CEVA
$855M
$32.1K ﹤0.01%
1,255
OPI
1681
DELISTED
Office Properties Income Trust
OPI
$31.8K ﹤0.01%
4,136
+463
+13% +$3.5K
FDMT icon
1682
4D Molecular Therapeutics
FDMT
$621M
$31.8K ﹤0.01%
1,762
CTBI icon
1683
Community Trust Bancorp
CTBI
$1.44B
$31.8K ﹤0.01%
894
TCMD icon
1684
Tactile Systems Technology
TCMD
$555M
$31.8K ﹤0.01%
1,275
+176
+16% +$3.66K
ALNT icon
1685
Allient
ALNT
$1.94B
$31.8K ﹤0.01%
795
YORW icon
1686
York Water
YORW
$528M
$31.7K ﹤0.01%
769
HY icon
1687
Hyster-Yale Materials Handling
HY
$614M
$31.7K ﹤0.01%
568
MODV
1688
DELISTED
ModivCare
MODV
$31.7K ﹤0.01%
701
SNBR
1689
DELISTED
Sleep Number
SNBR
$31.7K ﹤0.01%
1,161
CCSI icon
1690
Consensus Cloud Solutions
CCSI
$695M
$31.6K ﹤0.01%
1,018
DXPE icon
1691
DXP Enterprises
DXPE
$3.04B
$31.5K ﹤0.01%
865
PFC
1692
DELISTED
Premier Financial Corp. Common Stock
PFC
$31.4K ﹤0.01%
1,958
LYEL icon
1693
Lyell Immunopharma
LYEL
$347M
$31.3K ﹤0.01%
492
VTS icon
1694
Vitesse Energy
VTS
$685M
$31.3K ﹤0.01%
+1,398
New +$29.2K
EDIT icon
1695
Editas Medicine
EDIT
$432M
$31.3K ﹤0.01%
3,803
+680
+22% +$5.92K
TBI
1696
Trueblue
TBI
$302M
$31.2K ﹤0.01%
1,764
+292
+20% +$4.95K
ALHC icon
1697
Alignment Healthcare
ALHC
$2.8B
$31.2K ﹤0.01%
5,428
CLFD icon
1698
Clearfield
CLFD
$395M
$31.2K ﹤0.01%
658
BBUC
1699
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$5.93B
$31.2K ﹤0.01%
1,650
CNDT icon
1700
Conduent
CNDT
$241M
$31.1K ﹤0.01%
9,157

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 Portfolio in Review

As of Q2 2023, Metropolitan Life Insurance Company (MetLife) held 2,720 positions worth $2.06B, up 5.5% from $1.95B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 filing shows 413 new, 568 increased, 616 reduced and 259 closed positions. Its largest new stake was Alphabet (Google) Class C: 222,708 shares worth $26.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2023 buy was Alphabet (Google) Class C: 222,708 shares worth $26.9M.
  • Metropolitan Life Insurance Company (MetLife) added most to Vanguard Total Bond Market in Q2 2023, an estimated $15M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $16.1M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Iridium Communications in Q2 2023, selling an estimated $418K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 29% of its $2.06B portfolio in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 413 new positions and closed 259 in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 5.5% quarter-over-quarter to $2.06B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.